コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 that contain caspase-recruitment (CARD) and nucleotide-binding oligomerization domains.
2 e mediated by Toll-like receptors (TLRs) and nucleotide binding oligomerization domain 1 (Nod1) prote
4 so caused decreased stimulation of the human nucleotide-binding oligomerization domain 1 (Nod1) proin
5 le possesses potent stimulatory activity for nucleotide-binding oligomerization domain 1 (Nod1), an i
9 uridarum induces IFN-beta via stimulation of nucleotide-binding oligomerization domain 1 pathway, and
11 g to the development of colitis in mice with nucleotide binding oligomerization domain 2 (NOD2) defic
12 Retinoic acid-induced gene-I (RIG-I) and nucleotide binding oligomerization domain 2 (NOD2) serve
14 y few studies have addressed the function of nucleotide-binding oligomerization domain 2 (NOD-2) in t
16 itude of cytokine induction after individual nucleotide-binding oligomerization domain 2 (Nod2) and T
18 have confirmed prior findings related to the nucleotide-binding oligomerization domain 2 (NOD2) gene
19 immunity, the intracellular pathogen sensor nucleotide-binding oligomerization domain 2 (NOD2) has b
24 mutations and corresponding abnormalities of nucleotide-binding oligomerization domain 2 (NOD2) prote
25 actors regulating Crohn's disease-associated nucleotide-binding oligomerization domain 2 (Nod2) respo
26 models of colitis and the involvement of the nucleotide-binding oligomerization domain 2 (NOD2) signa
27 at correlate with the expression of CYLD and nucleotide-binding oligomerization domain 2 (NOD2), 2 st
28 by which mutations in CARD15, which encodes nucleotide-binding oligomerization domain 2 (NOD2), caus
29 dipeptide (MDP), the microbial activator of nucleotide-binding oligomerization domain 2 (Nod2), indu
31 ICOS and the ICOS ligand on MDDCs amplified nucleotide-binding oligomerization domain 2 (NOD2)-initi
32 Although Toll-like receptor 4 (TLR4)- and nucleotide-binding oligomerization domain 2 (NOD2)-media
35 ffects were mediated through binding to TLR2/nucleotide-binding oligomerization domain 2 and TLR3/MDA
36 ase domain with RIPK4's did not complement a nucleotide-binding oligomerization domain 2 signaling or
37 lasmatic pattern recognition receptor, NOD2 (nucleotide-binding oligomerization domain 2), belongs to
38 ted with impaired signaling through TLR2 and nucleotide-binding oligomerization domain 2, two recepto
39 enotype showed increased JAK2 expression and nucleotide-binding oligomerization domain 2-induced JAK2
40 AA carrier macrophages switched to increased nucleotide-binding oligomerization domain 2-induced proi
41 by the intracellular bacterial sensor NOD2 (nucleotide-binding, oligomerization domain 2) as an anti
42 tern recognition receptors (PRRs), including nucleotide-binding oligomerization domain-2 (NOD2) (vari
45 tion and function of Toll-like receptors and nucleotide-binding oligomerization domain-2, and mainten
46 mechanisms balancing toll-like receptor and nucleotide-binding-oligomerization domain activation in
47 , and mutation studies suggest that both the nucleotide binding oligomerization domain and the leucin
48 spase-1-activating proteins, which contain a nucleotide-binding oligomerization domain and leucine-ri
49 disrupted the ability of TRIM22 to regulate nucleotide binding oligomerization domain containing 2 (
51 ion of the IL-23/IL-17A axis is regulated by nucleotide-binding oligomerization domain containing (No
52 We hypothesized that polymorphisms in the nucleotide-binding oligomerization domain containing 2 (
53 ), IL10 -3575T>A (rs1800890, rs1800896), and nucleotide-binding oligomerization domain containing 2 (
54 activates innate immune cells by stimulating nucleotide-binding oligomerization domain containing 2 (
55 Recognition of symbiotic bacteria via the nucleotide-binding oligomerization domain containing 2 (
56 during streptozotocin (STZ)-induced T1D, the nucleotide-binding oligomerization domain containing 2 (
57 biochemical mechanism by which mutations in nucleotide-binding oligomerization domain containing 2 (
58 innate stimuli from house dust mite extract, nucleotide-binding oligomerization domain containing 2 l
60 he discovery that polymorphisms in the NOD2 (nucleotide-binding oligomerization domain containing 2)
61 gnition receptors, including TLR4, TLR7, and nucleotide-binding oligomerization domain containing 2,
63 of T-bet, intercellular adhesion molecule-1, nucleotide-binding oligomerization domain containing-2,
64 e of this study was to elucidate the role of nucleotide binding oligomerization domain-containing pro
66 MARCO was required for maximal TLR2- and nucleotide-binding oligomerization domain-containing (No
67 f the Crohn's disease susceptibility protein nucleotide-binding oligomerization domain-containing 2 (
69 6L-1), immunity-related GTPase-M (IRGM), and nucleotide-binding oligomerization domain-containing 2 (
70 mal regulation of the innate immune receptor nucleotide-binding oligomerization domain-containing pro
71 y, we found that activation of monocytes via nucleotide-binding oligomerization domain-containing pro
72 nd synergistically enhanced by activation of nucleotide-binding oligomerization domain-containing pro
74 on molecules, including Toll-like receptors, nucleotide-binding oligomerization domain-containing pro
76 ppressor of cytokine signaling-3, rs4969170; nucleotide-binding oligomerization domain-containing pro
77 nic chlamydial species are known to activate nucleotide-binding oligomerization domain-containing pro
78 k components of bacterial sensing, including nucleotide-binding oligomerization domain-containing pro
79 the cytoplasmic pattern recognition receptor nucleotide-binding oligomerization domain-containing pro
81 In this study, we investigated the role of nucleotide-binding oligomerization domain-containing pro
82 tes a specific pattern recognition molecule, nucleotide-binding oligomerization domain-containing pro
84 , such as nitric oxide, toll-like receptors, nucleotide-binding oligomerization domain-containing pro
87 recognition receptors (Toll-like receptor 2, Nucleotide-binding oligomerization domain-containing pro
89 gnaling via the pattern recognition receptor nucleotide-binding, oligomerization domain-containing pr
90 ow-derived macrophages from various TLRs and nucleotide-binding oligomerization domain-deficient mice
91 in 2, a component of the recently discovered nucleotide-binding oligomerization domain-dependent intr
92 the main cellular mechanisms responsible of nucleotide-binding oligomerization domain family, pyrin
94 e macrophages require Naip5, a member of the nucleotide-binding oligomerization domain leucine-rich r
96 , including IL-1 receptor (IL-1R) family and nucleotide-binding oligomerization domain, leucine-rich
97 attern-recognition receptor in the family of nucleotide-binding oligomerization domain-leucine-rich r
98 We analyzed the expression profile of NOD (nucleotide-binding oligomerization domain)-like receptor
101 of genes encoded for components of the TLR, nucleotide binding oligomerization domain-like receptor,
102 ith PGN inhibited cross-presentation through nucleotide-binding oligomerization domain-like receptor
103 t key roles for Toll-like receptor (TLR) and nucleotide-binding oligomerization domain-like receptor
105 of thioredoxin-interacting protein with the nucleotide-binding oligomerization domain-like receptor
106 or innate cytokines and signaling by TLR and nucleotide-binding oligomerization domain-like receptor
108 FN, apoptosis-associated speck-like protein, nucleotide-binding oligomerization domain-like receptor
109 c acid-inducible gene 1-like receptor (RLR), nucleotide-binding oligomerization domain-like receptor
111 s of the inflammasome, often proteins of the nucleotide-binding oligomerization domain-like receptor
113 how that the absent in melanoma 2 (AIM2) and nucleotide-binding oligomerization domain-like receptor
115 e define that the host mitochondrial protein nucleotide-binding oligomerization domain-like receptor
117 including, cytokine and chemokine signaling, nucleotide-binding oligomerization domain-like receptor
118 a secretion is mediated by activation of the nucleotide-binding oligomerization domain-like receptor
119 ansfected bone marrow-derived macrophages is nucleotide-binding oligomerization domain-like receptor
120 containing anti-dsDNA Abs by activating the nucleotide-binding oligomerization domain-like receptor
121 y, we show that cyclic stretch activates the nucleotide-binding oligomerization domain-like receptor
123 retinoic acid-inducible gene 1 (RIG-1), and nucleotide-binding oligomerization domain-like receptor
124 dies in mouse macrophages, activation of the nucleotide-binding oligomerization domain-like receptor
125 ammasome activation through interaction with nucleotide-binding oligomerization domain-like receptor
126 hisms in genes encoding Toll-like receptors, nucleotide-binding oligomerization domain-like receptor-
128 ven different human TLRs or one of two human nucleotide-binding oligomerization domain-like receptors
129 Caspase-1 activation triggered by multiple nucleotide-binding oligomerization domain-like receptors
131 e intracellular immunity receptors, known as nucleotide-binding oligomerization domain-like receptors
132 lysaccharide of Gram-negative microbes-while nucleotide-binding oligomerization domain-like receptors
133 eceptors (TLRs), cytosolic receptors such as nucleotide-binding oligomerization domain-like receptors
134 infection with a virulent microbe, TLRs and nucleotide-binding oligomerization domain-like receptors
136 tors, such as Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain-like receptors
141 tivation of the P2X7 purinergic receptor and nucleotide binding oligomerization domain (NOD)-like rec
142 Recent studies also identified the role of nucleotide binding oligomerization domain (NOD)-like rec
143 ffect of the T2S system was not dependent on nucleotide binding oligomerization domain (NOD)-like rec
149 of PRR such as Toll-like receptors (TLR) and nucleotide-binding oligomerization domain (NOD) proteins
152 philus influenzae (Hi) required both TLR and nucleotide-binding oligomerization domain (NOD) signalin
153 s, a growing family of proteins containing a nucleotide-binding oligomerization domain (NOD), are inv
154 , termed the inflammasome, by members of the nucleotide-binding oligomerization domain (Nod), leucine
155 ation of immune response pathways, including nucleotide-binding oligomerization domain (NOD)-, Toll-,
157 the areas of toll-like receptors (TLRs) and nucleotide-binding oligomerization domain (NOD)-containi
159 ar pattern recognition receptors such as the nucleotide-binding oligomerization domain (NOD)-like rec
160 protein complexes assembled by intracellular nucleotide-binding oligomerization domain (NOD)-like rec
163 mmasome scaffolds comprised of intracellular nucleotide-binding oligomerization domain (NOD)-like rec
167 also promote inflammation by activating the nucleotide-binding oligomerization domain (NOD)-like rec
168 yrin domain containing 1 (NLRP1), NLRP3, and nucleotide-binding oligomerization domain (NOD)-like rec
169 ptors (PRRs), such as Toll-like receptors or nucleotide-binding oligomerization domain (NOD)-like rec
170 which are structurally similar to mammalian nucleotide-binding oligomerization domain (NOD)-like rec
175 of primary peritoneal mesothelial cells via nucleotide-binding oligomerization domain (Nod)1, a memb
176 -regulation of toll-like receptor (TLR)2 and nucleotide-binding oligomerization domain (NOD)2 pathway
177 S: Polymorphisms that reduce the function of nucleotide-binding oligomerization domain (NOD)2, a bact
179 bial sensors, recent evidence indicates that nucleotide-binding oligomerization domains (NODs) can al
180 ssociated with missense mutations within the nucleotide-binding oligomerization domain of cryopyrin.
181 Intersections between toll-like receptor and nucleotide-binding-oligomerization domain pathways may e
184 the Toll-like receptors 1, 2, and 4 and the nucleotide-binding oligomerization domain protein 1 indu
186 in immune cells, although they activate the nucleotide-binding oligomerization domain proteins in tr
187 he lysosomal digestion products activate the nucleotide-binding oligomerization domain proteins.
188 Pathways activated by functional cytosolic nucleotide-binding-oligomerization domain proteins appea
190 ll-like receptor 1 (TLR1), TLR2, TLR4, TLR6, nucleotide-binding oligomerization domain receptor 1 (NO
191 ition is partially mediated by intracellular nucleotide-binding oligomerization domain receptors (NLR
192 lastic lesions in humanized fat pads of NOD (nucleotide-binding oligomerization domain)/SCID (severe
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。